Last 48 quarters of trend data · Healthcare · Medical Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -141.79 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 4.87 | 34.66 | 1.46 | 1.41 | 1.49 | 2.13 | 1.89 | 2.89 | 4.55 | 3.56 | 3.36 | 9.25 | 6.16 | 6.80 | 9.13 | 8.34 | 4.38 | 3.62 | 3.56 | 7.01 | 10.52 |
| — | +1530.4% | -22.7% | -51.2% | -67.3% | -40.3% | -43.6% | -68.8% | -26.2% | -47.6% | -63.2% | +10.9% | +40.7% | +87.6% | +156.7% | +19.0% | -58.4% | -76.9% | -71.3% | -45.4% | -46.6% | |
| P/B Ratio | — | — | — | — | — | — | — | — | 74.39 | 22.78 | 8.53 | 12.62 | 7.13 | 5.89 | 6.25 | 4.54 | 1.95 | 1.50 | 1.28 | 2.16 | 2.79 |
| — | — | — | — | — | — | — | — | +943.7% | +286.6% | +36.4% | +178.0% | +264.8% | +293.4% | +388.0% | +110.0% | -30.0% | -62.2% | -70.9% | -42.9% | -58.6% | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | 1213.95 | 37.31 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 82.1% | 84.0% | 81.9% | 81.7% | 81.2% | 81.3% | 81.2% | 84.7% | 87.6% | 83.7% | 86.1% | 86.4% | 87.3% | 84.5% | 81.2% | 84.2% | 85.8% | 83.2% | 83.4% | 76.4% | 88.2% |
| — | +3.3% | +0.9% | -3.5% | -7.3% | -2.8% | -5.7% | -1.9% | +0.3% | -1.0% | +6.0% | +2.6% | +1.9% | +1.6% | -2.5% | +10.2% | -2.8% | -1.6% | +4.1% | +1.2% | +5.1% | |
| Operating Margin | -59.4% | 93.8% | -31.6% | -45.7% | -59.1% | -53.6% | -60.5% | -63.9% | -54.1% | -70.6% | -102.8% | -155.0% | -86.5% | -68.2% | -95.0% | -93.9% | -62.5% | -63.2% | -76.3% | -125.8% | -122.2% |
| — | +274.9% | +47.8% | +28.4% | -9.2% | +24.1% | +41.1% | +58.8% | +37.4% | -3.6% | -8.2% | -64.9% | -38.4% | -7.9% | -24.5% | +25.3% | +48.9% | +25.4% | -67.2% | -84.1% | -10.7% | |
| Net Margin | -67.8% | -23.8% | -35.3% | -55.1% | -66.0% | -77.3% | -53.9% | -74.9% | -63.0% | -82.9% | -101.3% | -168.0% | -49.8% | -63.8% | -88.4% | -87.4% | -56.6% | -61.5% | -75.1% | -125.5% | -122.2% |
| — | +69.2% | +34.4% | +26.4% | -4.8% | +6.8% | +46.8% | +55.5% | -26.5% | -29.9% | -14.7% | -92.3% | +12.1% | -3.9% | -17.6% | +30.4% | +53.7% | +27.5% | -64.1% | -83.5% | -10.6% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | — | — | — | — | — | — | — | — | -138.6% | -89.7% | -54.5% | -45.7% | -12.6% | -13.2% | -14.2% | -11.4% | -6.2% | -6.2% | -6.6% | -9.3% | -7.8% |
| — | — | — | — | — | — | — | — | -998.7% | -577.4% | -283.7% | -302.4% | -103.5% | -113.9% | -116.0% | -21.5% | +21.0% | -18.2% | -63.5% | -39.2% | +13.0% | |
| ROA | -71.4% | -13.2% | -15.4% | -19.7% | -19.3% | -21.6% | -15.5% | -18.6% | -14.4% | -19.2% | -16.6% | -17.9% | -7.3% | -10.4% | -11.6% | -9.7% | -5.4% | -5.5% | -6.0% | -8.5% | -7.1% |
| — | +39.2% | +0.7% | -5.9% | -34.2% | -12.8% | +6.5% | -4.0% | -96.6% | -84.3% | -43.2% | -84.8% | -35.8% | -88.8% | -93.8% | -13.6% | +24.4% | -14.4% | -60.9% | -40.0% | +8.3% | |
| ROIC | -114.8% | 214.9% | -36.5% | -36.9% | -37.3% | -32.6% | -37.9% | -29.1% | -19.7% | -22.8% | -20.9% | -19.9% | -21.9% | -29.2% | -19.9% | -12.5% | -6.7% | -7.0% | -7.2% | -11.3% | -12.4% |
| — | +760.1% | +3.6% | -27.0% | -89.0% | -42.7% | -81.0% | -46.0% | +9.7% | +22.0% | -5.4% | -59.1% | -228.0% | -320.0% | -177.8% | -10.5% | +46.1% | +54.8% | +88.9% | +92.2% | +96.2% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | — | — | — | 10.22 | 3.73 | 1.89 | 1.37 | 0.86 | 0.04 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| — | — | — | — | — | — | — | — | +1082.3% | +8448.9% | +7500.1% | +5587.9% | +7880.3% | +246.9% | +331.6% | +225.4% | -30.8% | +26.7% | -24.3% | -16.7% | -24.7% | |
| Debt / EBITDA | — | 1.92 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 0.57 | 1.20 | 0.41 | 0.47 | 0.57 | 0.67 | 0.58 | 2.09 | 2.83 | 3.73 | 5.29 | 7.25 | 7.88 | 6.25 | 5.61 | 7.21 | 8.18 | 9.64 | 11.64 | 13.96 | 10.07 |
| — | +79.6% | -28.6% | -77.3% | -80.0% | -82.1% | -89.1% | -71.2% | -64.1% | -40.3% | -5.7% | +0.6% | -3.7% | -35.2% | -51.8% | -48.4% | -18.8% | -30.0% | -29.1% | -20.3% | +21.2% | |
| Quick Ratio | 0.46 | 0.99 | 0.34 | 0.38 | 0.46 | 0.55 | 0.46 | 1.72 | 2.47 | 3.37 | 4.81 | 6.64 | 7.46 | 5.88 | 5.39 | 6.96 | 7.98 | 9.44 | 11.39 | 13.68 | 9.84 |
| — | +79.9% | -26.7% | -77.8% | -81.5% | -83.6% | -90.5% | -74.1% | -66.9% | -42.7% | -10.9% | -4.5% | -6.6% | -37.7% | -52.7% | -49.1% | -18.9% | -30.1% | -29.7% | -20.7% | +22.7% | |
| Interest Coverage | -8.71 | 16.57 | -4.22 | -6.46 | -8.33 | -9.39 | -6.92 | -10.23 | -7.91 | -10.94 | -10.40 | -12.74 | -5.29 | — | — | — | — | — | — | — | -768.82 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying RCEL stock.
Avita Medical Inc.'s current P/E is -141.8x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Avita Medical Inc.'s current operating margin is -59.4%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Avita Medical Inc.'s business trajectory between earnings reports.